Trials / Unknown
UnknownNCT03193502
Efficacy and Safety of Rivaroxaban in the Management of Acute Non-neoplastic PVT Compensated Cirrhosis
Efficacy and Safety of Rivaroxaban in the Management of Acute Non-neoplastic Portal Vein Thrombosis in HCV Related Compensated Cirrhosis
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Sherief Abd-Elsalam · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
-Rivaroxaban is factor Xa inhibitor
Detailed description
PVT is a common complication of liver cirrhosis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | rivaroxaban | rivaroxaban |
Timeline
- Start date
- 2014-05-01
- Primary completion
- 2020-07-01
- Completion
- 2020-12-01
- First posted
- 2017-06-20
- Last updated
- 2017-10-13
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03193502. Inclusion in this directory is not an endorsement.